id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-338798-xsun927w	Ciorba, Andrea	Ototoxicity prevention during the SARS-CoV-2 (Covid-19) emergency	2020-10-17		.txt	text/plain	499	37	42	• To remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. • Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agent against SARS-CoV-2, during the pandemic, should be screened periodically, at least by OAEs. eventually adequate treatment is established (3) (4) (5) . Pure tone audiometry represents the main instrument for the identification and classification of hearing impairment; however, Otoacoustic Emissions (OAEs) are reported to be very sensitive in evaluating early manifestations of cochlear damages (6), as ototoxic drugs typically affect primarily outer hair cells (1, (3) (4) (5) . Therefore, healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agent against SARS-CoV-2, during the pandemic, should be screened periodically, at least by OAEs. Clearly, even without a fatal condition, it is important to avoid the onset of ototoxic manifestations, especially when chloroquine and hydroxychloroquine are administered with a prophylaxis intent.	./cache/cord-338798-xsun927w.txt	./txt/cord-338798-xsun927w.txt